Abstract
Purpose of Review
Periprosthetic joint infection (PJI) remains a complication that is associated with high morbidity as well as high healthcare expenses. The purpose of this review is to examine patient and perioperative modifiable risk factors that can be altered to help improve rates of PJI.
Recent Findings
Evidence-based review of literature shows that improved control of post-operative glycemia, appropriate management of obesity, malnutrition, metabolic syndrome, preoperative anemia, and smoking cessation can help minimize risk of PJI. Additionally, use of Staphylococcus aureus screening, preoperative evaluation of vitamin D levels, screening for urinary tract infection, and examination of dental hygiene can help with improving rates of PJI; similarly, appropriate management of perioperative variables such as limiting operating room traffic, appropriate timing, and selection of prophylactic antibiotics and surgical site preparation can help to decrease rates of PJI.
Summary
In summary, PJI is a morbid complication of total joint arthroplasty. Surgeons should be vigilant of modifiable risk factors that can be improved upon to help minimize the risk of PJI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Total hip and knee arthroplasties are among the fastest growing procedures in the USA [1]. However, periprosthetic joint infection (PJI) remains a significant complication that is associated with high morbidity as well as high healthcare expenses. It has a measurable impact on all parties involved including the patient, surgeon as well as the healthcare system [2]. PJI is projected to have an economic burden in excess of 1.62 billion dollars by the year 2020 [3]. This is especially important to address since estimates currently project large increases in demand for total hip and knee arthroplasties. By the year 2030, the demand for total hip arthroplasty is estimated to grow by 174% and the demand for total knee arthroplasties is projected to grow by 673% [4]. Similar increases are expected for revisions as well [4].
The incidence of deep periprosthetic infection after primary total hip and knee replacements has been reported in the literature to range anywhere from 0.5 to 2% [2, 5]. In examining total knee revision procedures, Bozic et al. showed that infection was the leading cause of revisions comprising 25% of all failures in TKA [6]. Other studies have also reported infection to be an important reason for patients undergoing revision in the total knee population with rates ranging from 33 to 38% [7, 8]. Kurtz et al. as also shown that infection is on the rise as a reason for revisions and will continue to be the dominant reason for necessitating revisions [9, 10].
It is important that we attempt to minimize the risk factors which can play a role in the development of PJI in the setting of such alarming trends. In particular, modifying risk factors from both the patient perspective as well as in the perioperative environment can help with decreasing the overall risk of developing a PJI. Multiple patient risk factors have been identified that can be altered prior to surgery to help minimize the risk of PJI.
Modifiable Risk Factors
Diabetes
Diabetes has been associated with increased risk of surgical site infection in a variety of surgical procedures [11, 12]. Additionally, the incidence of diabetes is continuing to rise in the USA [13]. In particular, patients with uncontrolled diabetes have been found to have an increased risk of infection of nearly 2.8 times after total joint arthroplasty [14].
Hemoglobin A1c (Hgb A1c) is frequently used as a marker of long-term glycemic control and may take 3 months to change. Patients with optimal glycemic control should have Hgb A1C levels less than 7.0. This corresponds to an estimated average glucose level of 154 mg/dL. Hgb A1c has frequently been used a routine screening test as it is a simple test which allows the provider to gain insight of the patient’s glycemic control over the past 3 months [15, 16]. However, it appears that perioperative glucose levels have an increased ability to predict PJI as opposed to Hgb A1c alone [17, 18•].
Surgical stress increases the production of hormones that antagonize insulin and predispose patients to hyperglycemia. In particular, perioperative glycemic control needs to be strictly enforced as surgical stress-related post-operative hyperglycemia, even in patients without a diagnosis of diabetes, has been found to have an independent risk factor for the development of surgical site infection in a dose-related relationship [19,20,21]. Thus, it is recommended that blood glucose levels be maintained between 110 and 180 mg/dL in the perioperative period to help minimize the risks associated with hyperglycemia. This can be achieved with frequent blood sugar checks and initiation of diabetic management protocols in the post-operative period.
Obesity
Similar to diabetes, the prevalence of obesity has also significantly increased. Obesity has been shown to significantly contribute to a higher rate of osteoarthritis and eventual increased use of arthroplasty [22]. While studies have shown that patient satisfaction and functional improvement in the obese patient population are similar to the non-obese group, obese patients are, nonetheless, at higher risk of postoperative complications, specifically PJI [23•]. Multiple studies have correlated increased body mass index (BMI) with increased rates of wound infection [24, 25]. Malinzak et al. showed that those with a BMI > 50 kg/m2 had 21.3 times greater odds of acquiring an infection [24].
Obesity predisposes patients to higher surgical times with increased surgical dissections needed to gain exposure. Additionally, the poor vascularization of adipose tissue further compounds this problem. Surgeons should also have a high index of suspicion for metabolic syndrome in those with obesity.
A workgroup of the American Association of Hip and Knee Surgeons (AAHKS) evidence-based committee came up with a consensus opinion that consideration should be given to delaying total joint arthroplasty in a patient with a BMI > 40, especially when associated with other comorbid conditions, such as poorly controlled diabetes or malnutrition [22].
Metabolic Syndrome
Metabolic syndrome is composed of a cluster of conditions arising from insulin resistance that impairs normal leukocyte function. It is defined as having a BMI > 30 kg/m2 with central obesity, as well as two of the following: hyperlipidemia, hyperglyceridemia, hypertension, or diabetes [26]. Zmistowski et al. have shown increased risk of PJI (14.3 vs 0.8%) in those with uncontrolled metabolic syndrome compared to those with controlled disease/healthy cohort [27].
Malnutrition
An often-underappreciated facet of obesity involves malnutrition, or so called paradoxical malnutrition in obese patients that have high caloric but nutritionally poor diets. A prospective study evaluating the role of malnutrition in total joint arthroplasty found that malnutrition was present in 42.9% of obese patients [28]. Additionally, the geriatric population, patients with gastrointestinal problems, patients with a history of alcohol abuse, and cancer are also at increased risk of malnutrition. Multiple studies have implicated that malnutrition has a contributing factor to increasing the risk of a PJI [29, 30]. Specifically, patients with malnutrition were found to have 5 to 7 times greater risk of developing a major wound complication [31]. Malnutrition has also been associated with an increased risk of infection in patients undergoing revision total joint arthroplasty [32•].
Simple and immediately available laboratory tests can help to identify patients at risk for malnutrition. These include a total lymphocyte count of less than 1500 cells/mm3, a serum albumin of less than 3.5 g/dL, or a transferrin level of less than 200 mg/dL [29]. Patients with pre-operative malnutrition should be encouraged to work with a dietician to improve their nutritional intake and help prepare them for the catabolic demands required in the post-surgical period.
Smoking
Smoking, and its primary offending component, nicotine, has been associated with microvascular constriction and decreased oxygen delivery to tissues [33, 34]. In particular when analyzing the effects of smoking on total joint arthroplasty, Duchman et al. reported increased risk of wound complication with both current as well as well as former smokers in a large national database study with current smokers having higher rate of wound complications than former smokers [35, 36•]. Additional studies have also corroborated the deleterious effects of smoking as it pertains to PJI [37].
It has been shown that a smoking cessation program can help decrease complications associated with the use of nicotine even if it is introduced as late as 4 weeks before surgery [38]. Thus, it is our recommendation that patient undergoing total joint arthroplasty has a minimum period of 4 weeks of smoking cessation prior to their surgery. Smoking cessation can be confirmed via easily available laboratory test, the serum cotinine assay (normal value of ≤ 10 ng/dL) [39]. Patients undergoing smoking cessation therapy using transdermal nicotine patches continue to test positive for serum cotinine as the nicotine continues to be absorbed systemically [40, 41].
Staphylococcus aureus Screening
The prevalence of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients admitted to hospitals is increasing [42]. Nasal swab rapid polymerase chain reaction has allowed physicians to identify patients who are colonized. This allows for the elimination of the bacteria from the patient’s nasal flora prior to surgery. Kim et al. have found that implementing an institution wide prescreening program allows for the identification of carrier status of Staphylococcus aureus among patients and leads to significant reduction in post-operative rates of surgical site infections [43]. Similarly, Rao et al. noted that implementation of an institutional decolonization protocol helped to decrease overall infection rate and resulted in significant economic gains for the hospital [44]. It is our recommendation that patients undergoing elective total joint arthroplasty undergo screening for S. aureus through nasal swabs. If they are positive, we recommend that they undergo application of mupirocin nasal ointment twice daily to both nares and bathe with chlorhexidine daily for 5 days immediately prior to the scheduled surgery. Alternatively, patients can also be treated with nasal povidone-iodine swabs which have demonstrated reduction in the colonization of S. aureus [45]. In addition, patients who screen positive for MRSA should also receive a single dose of vancomycin along with standard perioperative antibiotics.
Urinary Tract Infection
Urinary tract infection (UTI) is a common nosocomial infection that creates a reservoir of pathogens and increases patient morbidity [46]. Prolonged postoperative urinary catheter use has been identified as a significant risk factor for the development of UTI [47]. The role of UTI in the development of PJI, however, remains controversial. Some authors have noted the development of PJI in patients with UTI [48,49,50] while others have shown no association between UTI and PJI [46, 51].
It is our recommendation that if the patient has symptoms of UTI such as dysuria, urgency, frequency, etc. and has more than 1 × 103 bacteria/mL of urine, postponement of the surgery should be considered. However, if the patient is asymptomatic but has 1 × 103 or more bacteria/mL of urine, we recommend not withholding surgery but seeking to treat the UTI with a routine course of postoperative oral antibiotic.
Poor Oral Health
It has been noted in the literature that patients who have had total joint replacements practice good dental hygiene in general [52•]. However, there is a lack of literature on the role of pre-operative screening and its association with PJI. Recent studies have questioned the need to obtain routine preoperative dental screening for hip and knee arthroplasty patients [53]. In general, it is our recommendation to follow a common-sense approach. Patients should have a dental exam and clearance if they have evidence of decayed teeth, abscess, gingivitis, or periodontitis and should have routine cleanings done prior to surgical intervention.
Immunosuppression
Acquired immunodeficiency syndrome (AIDS) is a sequelae that frequently develops in patients with human immunodeficiency virus (HIV) when their CD4+ T cell count falls below 200 cells per μL or when they develop specific diseases in association with an HIV infection. The literature has only small series of patients with HIV/AIDS who have undergone total joint arthroplasty with mixed results [54, 55]. Parvizi et al. reported high rates of deep infection (28.6%) in their series [55]. In this high-risk patient population, it is our recommendation that the surgeon and patient work in conjunction with an infectious disease consultant to ensure that these patients are optimized thoroughly prior to their surgical intervention. Specifically, heightened awareness should be taken in those with a CD4 count less than 200 and in those with a viral load greater than 10,000 copies/mL.
Inflammatory Arthropathies
Patients with inflammatory arthropathies such as rheumatoid arthritis and systemic lupus erythematosus are often at increased risk of post-operative infection [56, 57]. Many of these patients are on complex drug regimen that include a variety of immunomodulators. These medications often have deleterious effects on wound healing and infections. For example, tumor necrosis factor (TNF) alpha inhibitors are tremendously helpful adjuncts in the management of these diseases. However, they place patients at significant risk for developing opportunistic infections. Momohara et al. reported patients on TNF alpha inhibitors to be at higher risk for surgical site infections [58]. A recent guideline published jointly by the American College of Rheumatology and American Association of Hip and Knee Surgeon used available evidence to make recommendations on which medications should be stopped in elective total joint arthroplasty and if withheld, when they should be restarted [59•]. In general, traditional Disease Modifying Antirheumatic Medications (DMARDS), such as methotrexate, do not need to be withheld prior to surgery. Biologicals, however, place patients at increased risk for development of PJI and should be withheld one dosing cycle prior to surgery. The medication can be re-started following surgery once surgical wounds have healed and in the absence of signs of infection.
Preoperative Anemia
Preoperative anemia has been found to increase complication rates in patients undergoing total joint replacement including development of PJI [60,61,62]. Additionally, correction of preoperative anemia with postoperative transfusion has been associated with increased risk of infection of up to 9% with each unit of blood that is transfused [63, 64]. This increased risk is thought to occur through transfusion-related immunomodulation [65]. It is our recommendation that patients identified as having preoperative anemia, defined as Hgb < 13 g/dL for men and Hgb < 12 g/dL for women, work with their primary care doctor in optimizing their hemoglobin levels preoperatively though adjuncts such as improved nutrition, and the use of erythropoietin prior to their surgical intervention. Additionally, the surgeon should also strongly consider the use of blood conservation tools during the procedure such as the use of tranexamic acid.
Vitamin D
Vitamin D, as measured by serum 25-hydroxyvitamin D, has long been known to play a crucial role in bone hemostasis [66]. Vitamin D deficiency, defined by a serum 25-hydroxyvitamin D concentration ≤ 20 ng/mL, is unfortunately quite common in the US population with an overall prevalence reported at 41.6% [67]. Studies have shown vitamin D levels to be severely low in patients with PJI [68, 69•]. Animal models have also shown that while deficiency of vitamin D results in increased risk of PJI, this can be reversed with preoperative repletion [69•]. Thus, it is our recommendation that vitamin D levels be obtained preoperatively and if deficient, < 20 ng/ mL, supplementation be instituted.
Perioperative Modifiable Risk Factors
Antibiotic Prophylaxis
Administration of preoperative antibiotic prophylaxis is effective in reducing rates of surgical site infections [70]. Routine prophylactic antibiotics, dosed in accordance with the patient’s weight, should include a first-generation cephalosporin such as cefazolin. Patients who are allergic to beta lactam antibiotic should receive clindamycin or vancomycin. However, timing is also equally important as the choice of antibiotic. Prophylactic antibiotics should be administered ideally as near to the time of the incision as possible, but within 60 min prior to the incision for a first-generation cephalosporin or clindamycin, and within 2 h of incision for vancomycin. We recommend that weight-based dosage of vancomycin be considered for those who have been shown to be colonized with MRSA or those who had a prior infection with MRSA [71]. Additionally, we recommend that antibiotics be discontinued within 24 h after the surgical procedure.
Surgical Site Preparation
Current evidence recommends the use of chlorhexidine gluconate-based solutions for surgical site preparations and has been found to be superior to the use of iodophor-based solutions as well as other iodine ion-based solution at reducing the burden of microbes at the surgical site. Chlorhexidine gluconate acts by disrupting the cellular membranes of bacteria and is longer acting than iodophors. While chlorhexidine gluconate and povidone-iodine both reduce bacterial counts on contact, the effect is much longer with chlorhexidine [72, 73]. Additionally, iodophors can be inactivated by serum proteins and should be allowed to dry in order to maximize their antimicrobial action [72]. Alcohol is also a potent antimicrobial. However, it lacks residual activity after application. Our recommendation is the use of a combination agent that involves both chlorhexidine gluconate as well as isopropyl alcohol. Hair removal is another facet of surgical site preparation that can potentially play a role in increasing surgical site infections. We recommend that hair removal be minimized and if necessary, and that electric clippers be used rather than shavers in accordance with the Centers for Disease Control and Prevention guidelines [74].
Operating Room Environment
Several operating room variables have been studied to see if rates of infection could be decreased in total joint replacement patients. These include the use of ultraviolet light, laminar flow, body exhaust suits, etc. However, maintaining a disciplined operating room by limiting operating room traffic has been shown to decrease the rate of surgical site infections [75, 76]. Thus, it is crucial that traffic into and out of the operating room through both the sterile core as well as the common corridor be limited during arthroplasty procedures to decrease the risk of surgical site infections.
Conclusion
The well-known idiom, an ounce of prevention is worth a pound of cure, is certainly applicable to PJI. While PJI will not be completely eliminated in the coming years, surgeons should make use of available evidence-based guidelines, such as the ones proposed above, to help improve patient and perioperative modifiable risk factors to minimize risk of PJI.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467(10):2606–12.
Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87(8):1746–51.
Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplast. 2012;27(8 Suppl):61–5 e1.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.
Sculco TP. The economic impact of infected total joint arthroplasty. Instr Course Lect. 1993;42:349–51.
Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468(1):45–51.
Fehring TK, Odum S, Griffin WL, Mason JB, Nadaud M. Early failures in total knee arthroplasty. Clin Orthop Relat Res. 2001;392:315–8.
Vessely MB, Whaley AL, Harmsen WS, Schleck CD, Berry DJ. The Chitranjan Ranawat award: long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties. Clin Orthop Relat Res. 2006;452:28–34.
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplast. 2008;23(7):984–91.
Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468(1):52–6.
Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408–14.
Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clin Microbiol Infect. 2015;21(Suppl 2):S27–32.
Klonoff DC. The increasing incidence of diabetes in the 21st century. J Diabetes Sci Technol. 2009;3(1):1–2.
Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91(7):1621–9.
Stryker LS, Abdel MP, Morrey ME, Morrow MM, Kor DJ, Morrey BF. Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty. J Bone Joint Surg Am. 2013;95(9):808–14. S1-2
Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141(4):375–80. discussion 80
Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplast. 2012;27(5):726–9. e1
• Chrastil J, Anderson MB, Stevens V, Anand R, Peters CL, Pelt CE. Is hemoglobin A1c or perioperative hyperglycemia predictive of Periprosthetic joint infection or death following primary Total joint arthroplasty? J Arthroplast. 2015;30(7):1197–202. New data seems to suggest that perioperative hyperglycemia may be a better target for optimization to decrease the burden of PJI.
Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607–12.
Richards JE, Kauffmann RM, Obremskey WT, May AK. Stress-induced hyperglycemia as a risk factor for surgical-site infection in nondiabetic orthopedic trauma patients admitted to the intensive care unit. J Orthop Trauma. 2013;27(1):16–21.
Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858–64.
Workgroup of the American Association of H, Knee Surgeons Evidence Based C. Obesity and total joint arthroplasty: a literature based review. J Arthroplast. 2013;28(5):714–21.
• Mason JB, Callaghan JJ, Hozack WJ, Krebs V, Mont MA, Parvizi J. Obesity in total joint arthroplasty: an issue with gravity. J Arthroplast. 2014;29(10):1879. Commentary in the Journal of Athroplasty highlighting studies which have shown obesity to be associated with worse outcomes including infection.
Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplast. 2009;24(6 Suppl):84–8.
Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am. 1998;80(12):1770–4.
Gage MJ, Schwarzkopf R, Abrouk M, Slover JD. Impact of metabolic syndrome on perioperative complication rates after total joint arthroplasty surgery. J Arthroplast. 2014;29(9):1842–5.
Zmistowski B, Dizdarevic I, Jacovides CL, Radcliff KE, Mraovic B, Parvizi J. Patients with uncontrolled components of metabolic syndrome have increased risk of complications following total joint arthroplasty. J Arthroplast. 2013;28(6):904–7.
Huang R, Greenky M, Kerr GJ, Austin MS, Parvizi J. The effect of malnutrition on patients undergoing elective joint arthroplasty. J Arthroplast. 2013;28(8 Suppl):21–4.
Ellsworth B, Kamath AF. Malnutrition and total joint arthroplasty. J Nat Sci. 2016;2(3)
Courtney PM, Rozell JC, Melnic CM, Sheth NP, Nelson CL. Effect of malnutrition and morbid obesity on complication rates following primary Total joint arthroplasty. J Surg Orthop Adv. 2016;25(2):99–104.
Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplast. 1991;6(4):321–5.
• Yi PH, Frank RM, Vann E, Sonn KA, Moric M, Della Valle CJ. Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty? Clin Orthop Relat Res. 2015;473(1):175–82. Study that found that patients with evidence suggestive of malnutrition to be independently associated with acute postoperative infection in the revision arthroplasty setting.
Moller AM, Pedersen T, Villebro N, Munksgaard A. Effect of smoking on early complications after elective orthopaedic surgery. J Bone Joint Surg (Br). 2003;85(2):178–81.
Sorensen LT, Jorgensen S, Petersen LJ, Hemmingsen U, Bulow J, Loft S, et al. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. J Surg Res. 2009;152(2):224–30.
Duchman KR, Gao Y, Pugely AJ, Martin CT, Noiseux NO, Callaghan JJ. The effect of smoking on short-term complications following Total hip and knee arthroplasty. J Bone Joint Surg Am. 2015;97(13):1049–58.
• Cherian JJ, Mont MA. Where there is smoke, there is fire! Commentary on an article by Kyle R Duchman, MD, et al: “The Effect of Smoking on Short-Term Complications Following Total Hip and Knee Arthroplasty”. J Bone Joint Surg Am. 2015;97(13):e53. Both current and former smokers are at higher risk of developing post operative wound infection.
Teng S, Yi C, Krettek C, Jagodzinski M. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies. PLoS One. 2015;10(4):e0125294.
Lindstrom D, Sadr Azodi O, Wladis A, Tonnesen H, Linder S, Nasell H, et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg. 2008;248(5):739–45.
Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: the third National Health and nutrition examination survey, 1988 to 1991. JAMA. 1996;275(16):1233–40.
Gariti P, Alterman AI, Barber W, Bedi N, Luck G, Cnaan A. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. Drug Alcohol Depend. 1999;54(2):111–6.
Hurt RD, Dale LC, Offord KP, Lauger GG, Baskin LB, Lawson GM, et al. Serum nicotine and cotinine levels during nicotine-patch therapy. Clin Pharmacol Ther. 1993;54(1):98–106.
Goyal N, Aggarwal V, Parvizi J. Methicillin-resistant Staphylococcus aureus screening in total joint arthroplasty: a worthwhile endeavor. J Knee Surg. 2012;25(1):37–43.
Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010;92(9):1820–6.
Rao N, Cannella B, Crossett LS, Yates AJ Jr, McGough R 3rd. A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res. 2008;466(6):1343–8.
Peng HM, Wang LC, Zhai JL, Weng XS, Feng B, Wang W. Effectiveness of preoperative decolonization with nasal povidone iodine in Chinese patients undergoing elective orthopedic surgery: a prospective cross-sectional study. Braz J Med Biol Res. 2017;51(2):e6736.
Koulouvaris P, Sculco P, Finerty E, Sculco T, Sharrock NE. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res. 2009;467(7):1859–67.
Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991;91(3B):65S–71S.
Cruess RL, Bickel WS, vonKessler KL. Infections in total hips secondary to a primary source elsewhere. Clin Orthop Relat Res. 1975;106:99–101.
David TS, Vrahas MS. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg. 2000;8(1):66–74.
Sousa R, Munoz-Mahamud E, Quayle J, Dias da Costa L, Casals C, Scott P, et al. Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis. 2014;59(1):41–7.
Glynn MK, Sheehan JM. The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res. 1984;185:151–4.
• Wood TJ, Petruccelli D, Piccirillo L, Staibano P, Winemaker M, de Beer J. Dental hygiene in maintaining a healthy joint replacement: a survey of Canadian total joint replacement patients. COP. 2016;27(5):515–9. Most arthroplasty patients appear to have good dental hygiene in this Canadian study.
Lampley A, Huang RC, Arnold WV, Parvizi J. Total joint arthroplasty: should patients have preoperative dental clearance? J Arthroplast. 2014;29(6):1087–90.
Lin CA, Takemoto S, Kandemir U, Kuo AC. Mid-term outcomes in HIV-positive patients after primary total hip or knee arthroplasty. J Arthroplast. 2014;29(2):277–82.
Parvizi J, Sullivan TA, Pagnano MW, Trousdale RT, Bolander ME. Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplast. 2003;18(3):259–64.
Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheum. 2014;66(2):254–63.
Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E, et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 2012;64(12):3839–49.
Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;21(5):469–75.
• Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplast. 2017;32(9):2628–38. Important guidelines on the management of antirheumatic medications including continuing methotrexate in the perioperative period and holding biologics.
Viola J, Gomez MM, Restrepo C, Maltenfort MG, Parvizi J. Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty. J Arthroplast. 2015;30(5):846–8.
Lu M, Sing DC, Kuo AC, Hansen EN. Preoperative Anemia independently predicts 30-day complications after aseptic and septic revision Total joint arthroplasty. J Arthroplast. 2017;32(9S):S197–201.
Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012;470(10):2695–701.
Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplast. 2004;19(3):281–7.
Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124–57.
Corwin HL. Blood conservation in the critically ill patient. Anesthesiol Clin North Am. 2005;23(2):363–72. viii
St-Arnaud R. The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys. 2008;473(2):225–30.
Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54.
Maier GS, Horas K, Seeger JB, Roth KE, Kurth AA, Maus U. Is there an association between periprosthetic joint infection and low vitamin D levels? Int Orthop. 2014;38(7):1499–504.
• Hegde V, Dworsky EM, Stavrakis AI, Loftin AH, Zoller SD, Park HY, et al. Single-dose, preoperative vitamin-D supplementation decreases infection in a mouse model of Periprosthetic joint infection. J Bone Joint Surg Am. 2017;99(20):1737–44. Early animal model studies seem to indicate that Vitamin D supplementaton decreases infection risk.
Fernandez AH, Monge V, Garcinuno MA. Surgical antibiotic prophylaxis: effect in postoperative infections. Eur J Epidemiol. 2001;17(4):369–74.
Kheir MM, Tan TL, Azboy I, Tan DD, Parvizi J. Vancomycin prophylaxis for Total joint arthroplasty: incorrectly dosed and has a higher rate of Periprosthetic infection than cefazolin. Clin Orthop Relat Res. 2017;475(7):1767–74.
Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am. 2007;89(7):1605–18.
Bosco JA 3rd, Slover JD, Haas JP. Perioperative strategies for decreasing infection: a comprehensive evidence-based approach. J Bone Joint Surg Am. 2010;92(1):232–9.
Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43(3):322–30.
Allo MD, Tedesco M. Operating room management: operative suite considerations, infection control. Surg Clin North Am. 2005;85(6):1291–7. xii
Babkin Y, Raveh D, Lifschitz M, Itzchaki M, Wiener-Well Y, Kopuit P, et al. Incidence and risk factors for surgical infection after total knee replacement. Scand J Infect Dis. 2007;39(10):890–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Bryan D. Springer reports board membership with AJRR and ICJR, consultancy fees from Stryker, Convatec, and Osteoremedies, lecture fees from Ceramtec, and royalties from Stryker, outside of the submitted work.
Vignesh K. Alamanda reports no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Prosthetic Joint Infection
Rights and permissions
About this article
Cite this article
Alamanda, V.K., Springer, B.D. Perioperative and Modifiable Risk Factors for Periprosthetic Joint Infections (PJI) and Recommended Guidelines. Curr Rev Musculoskelet Med 11, 325–331 (2018). https://doi.org/10.1007/s12178-018-9494-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12178-018-9494-z